Nabilone Market

Nabilone Market Size, Share & Industry Analysis, By Source (Pharmaceutical Manufacturers (Branded & Generic), Contract Manufacturing Organizations (CMOs), Research-Grade Suppliers.) By End-User (Pharmaceutical Industry, Hospitals & Clinics, Research Institutions) and Forecast, 2025-2035

The Nabilone market is projected to grow at a CAGR of 7.5% from 2025 to 2035, driven by increasing demand for medical cannabis alternatives and expanding clinical applications for nausea, pain, and mental health treatment. Nabilone is a synthetic cannabinoid analog of tetrahydrocannabinol (THC), primarily used in the treatment of chemotherapy-induced nausea and vomiting (CINV) and chronic pain management. It works by binding to cannabinoid receptors in the brain, which helps modulate pain perception, reduce nausea, and alleviate other symptoms.

The market is also supported by the growing recognition of cannabinoids as effective treatments for conditions like post-traumatic stress disorder (PTSD), anxiety, and sleep disorders. Nabilone is favored in cases where traditional medications fail to provide adequate relief or cause intolerable side effects. Additionally, its FDA approval for CINV treatment has established it as a key player in oncology care.

North America dominates the Nabilone market, largely due to widespread acceptance of cannabinoid-based therapies, particularly in the United States and Canada, where medical cannabis products have gained greater legitimacy. Europe follows closely, with growing adoption in the UK and Germany for oncology and mental health uses. The Asia-Pacific region is anticipated to experience steady growth as medical cannabis regulations evolve, and awareness of cannabinoid-based therapies increases.

Seeking Comprehensive Intelligence on Different markets? Get in Touch with our Experts

Report Scope & Segmentation

Introduction

Overview of Nabilone
Key Applications & Industry Use Cases
Market Scope & Study Objectives

Market Overview

Global Market Size & Growth Trends (Historical & Forecast)
Market Value & Revenue Analysis
Demand-Supply Dynamics

Segmental Outlook

By Source
- Pharmaceutical Manufacturers (Branded & Generic)
- Contract Manufacturing Organizations (CMOs)
- Research-Grade Suppliers
Key End-Use Industries
- Pharmaceutical Industry.
- Hospitals & Clinics.
- Research Institutions.

Price Analysis

Current Price Trends (Per kg & Per Ton)
Price Fluctuation Factors (Raw Material Costs, Production, Trade Tariffs)
Regional Price Comparison (North America, Europe, Asia-Pacific, and Other)

Production & Supply Volume

Global Production Capacity & Key Manufacturers
Production Process & Technological Developments
Raw Material Analysis

Trade Analysis (Import & Export)

Major Exporting & Importing Countries
Trade Volume & Value Statistics
Impact of Trade Regulations & Policies

Regional Analysis

North America (US and Canada)
Europe (UK, Germany, France, Italy, Spain, and Rest of Europe)
Asia-Pacific (China, Japan, South Korea, Taiwan, India, and Rest of Asia-Pacific)
Rest of the World (Latin America, Middle East, and Africa)

Competitive Landscape

Top Global Manufacturers & Market Share
Company Profiles & Key Developments
Mergers, Acquisitions & Investments

Regulatory & Compliance Factors

FDA, REACH, and Other Regulatory Frameworks
Environmental & Safety Considerations
Emerging Policies Impacting Market Growth

Conclusion & Strategic Recommendations

Key Takeaways for Stakeholders
Market Entry Strategies

May 23, 2025

What is Nabilone?

Nabilone is a synthetic cannabinoid that is chemically like THC (tetrahydrocannabinol), the active compound in cannabis. It is primarily used to treat nausea and vomiting associated with chemotherapy in cancer patients who have not responded to other antiemetic treatments.

What is the market growth of Nabilone?

The global market for Nabilone is projected to grow at a CAGR of 7.5% from 2025 to 2035, Market growth is driven by increasing acceptance of cannabinoids for medical use, expanding indications for its therapeutic use, and growing awareness of its benefits in managing chemotherapy-induced nausea, chronic pain, and other medical conditions.

What are the drivers of the Nabilone market?

Key drivers for the Nabilone market include the increasing number of cancer patients undergoing chemotherapy, leading to a higher demand for effective antiemetic drugs. Additionally, the rising prevalence of chronic pain conditions such as fibromyalgia and neuropathy.

Who are the key players operating in the Nabilone market?

The key players in the Nabilone market include Aphria Inc. (now part of Tilray), which markets Nabilone under the brand name Cesamet, and Valeant Pharmaceuticals (now known as Bausch Health Companies Inc.), which holds the rights for its distribution in various regions.

Which region will exhibit the fastest growth in the Nabilone market?

North America is expected to exhibit the fastest growth in the Nabilone market, driven by the increasing adoption of cannabinoid-based therapies, expanding medical marijuana programs, and the rising number of patients undergoing chemotherapy who require antiemetic treatments.

$1800/- Single User License
$3600/- Multi User License

Experienced in market research and consulting.
Seasoned professionals with diverse industry knowledge.
Proven track record in delivering valuable insights.
Tailored methodologies for unique client needs.
End-to-end services: market analysis, competitor intelligence, consumer behavior, and strategic recommendations.
Latest tools and tech for data collection, analysis, and visualization.
Embrace of AI and machine learning for deeper insights.
Global capabilities and extensive network.
In-depth understanding of international markets, trends, and regulations.
Dedicated to addressing specific client needs and goals.
Focus on delivering value through efficient research outcomes.

How can we help you?

Reach out to discuss how our team can help your business achieve real results.

Contact Person

Mr. Anurag Tiwari

Call Us

+91-780-304-0404

Mail Us

info@omrglobal.com